![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » VENUS REMEDIES LAUNCHES CEPHALOSPORINS IN DOMESTIC MARKETS
VENUS REMEDIES LAUNCHES CEPHALOSPORINS IN DOMESTIC MARKETS
September 6, 2005
Venus Remedies Ltd on Monday said that it has launched a commercially innovative formulation, a fixed dose combination of Cephalosporins, in domestic markets. The new product is a cure for bacterial meningitis, which till now did not have a specific medication for treatment, the company informed the Bombay Stock Exchange. The company has entered into a strategic marketing tie-up with Elder Pharmaceuticals, for the right placement of its new formulation in its niche segment, it said.
The Hindu Business Line (http://www.thehindubusinessline.com/blnus/02051308.htm)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct